Intellectual Property India Publishes Patent Application for Crystalline Hydrochloride And Fumarate Salts Of N-Ethyl-2- (5-Fluoro-1h-Indol-3-Yl)-N- Methylethan-1-Amine

MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617019998 A) filed by Gilgamesh Pharmaceuticals, Inc. on February 20, 2026, for Crystalline Hydrochloride And Fumarate Salts Of N-Ethyl-2- (5-Fluoro-1h-Indol-3-Yl)-N- Methylethan-1-Amine.

Inventors include Kruegel, Andrew Carry; Leong, William; He, Yameng; and Maceachern, Lauren.

The application for the patent was published on August 07, 2026, under issue no. 32/2026.

Abstract: The present disclosure relates to a crystallinesalt selected from crystalline N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine fumarate and crystalline N-ethyl- 2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine hydrochloride, method of preparing them, and use thereof for treating mood disorders. In addition, the present disclosure relates to polymorphs of the aforementioned salts. Further, the present disclosure relates to an oil or amorphous N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N- methylethan-1-amine, method of preparing the same and use thereof for treating mood disorders.

Disclaimer: Curated by HT Syndication.